Publications by authors named "Hideo Nakamura"

Background: Combination therapy with BRAF and MEK inhibitor holds promise for treating gliomas harboring the V600E mutation; however, the development of acquired resistance remains a challenge.

Case Description: We describe a case of repeated recurrent mutant pleomorphic xanthoastrocytoma (central nervous system World Health Organization grade 3) treated with combination therapy with BRAF and MEK inhibitor. The patient received dabrafenib (BRAF inhibitor) and trametinib (MEK inhibitor); however, she developed resistance to the combination therapy.

View Article and Find Full Text PDF

We report a case of pediatric glioma with uncommon imaging, morphological, and genetic features. A one-year-old boy incidentally presented with a tumor in the fourth ventricle. The tumor was completely resected surgically and investigated pathologically.

View Article and Find Full Text PDF

Purpose: Intratumoral thrombosis is a specific finding in glioblastomas and considered the origin of palisading necrosis. Its distribution and contribution to the glioblastoma pathophysiology and systemic thrombosis are obscure, although deep vein thrombosis is a common complication in glioblastoma cases.

Methods: Clinicopathological and genetic analyses were performed on 97 glioblastoma tissue specimens to elucidate the role of thrombotic events and associated molecular abnormalities.

View Article and Find Full Text PDF

The goal of treating patients with suprasellar meningioma is improving or preserving visual function while achieving long-term tumor control. We retrospectively examined patient and tumor characteristics and surgical and visual outcomes in 30 patients with a suprasellar meningioma who underwent resection via an endoscopic endonasal (15 patients), sub-frontal (8 patients), or anterior interhemispheric (7 patients) approach. Approach selection was based on the presence of optic canal invasion, vascular encasement, and tumor extension.

View Article and Find Full Text PDF
Article Synopsis
  • Pineal parenchymal tumors of intermediate differentiation (PPTIDs) are rare brain tumors, making up less than 1% of CNS tumors, which creates challenges for diagnosis and treatment.* -
  • A study across 11 institutions identified 28 patients with PPTID, with findings showing a median age of 49, a predominance of females, and a gross total resection success rate of 46%.* -
  • The study concluded that female sex and gross total resection are important factors for better patient outcomes, with a high occurrence of leptomeningeal recurrences and KBTBD4 mutations present in most patients.*
View Article and Find Full Text PDF

Pharmacotherapy is frequently selected over surgical interventions for late elderly patients with trigeminal neuralgia (TN). However, medication may affect these patients' activities of daily living (ADL). Hence, we investigated the effect of the surgical treatment of TN on ADL in older patients.

View Article and Find Full Text PDF

Objective: An autologous formalin-fixed tumor vaccine (AFTV) derived from resected glioblastoma (GBM) tissue can be used against unidentified tumor antigens. Thus, the authors conducted a multicenter double-blind phase IIb trial to investigate the efficacy of an AFTV.

Methods: Eligible patients were adults with supratentorial GBMs, 16-75 years of age, with Karnofsky Performance Scale (KPS) scores ≥ 60%, and no long-term steroid administration.

View Article and Find Full Text PDF

Background: Primary central nervous system (CNS) germ cell tumors (GCTs) are rare neoplasms predominantly observed in the pediatric and young adult populations. A mixed GCT including immature teratoma exhibiting growing teratoma syndrome is presented. The pathogenesis of growing teratoma syndrome remains unclear, and its treatment strategy has not been established.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the effectiveness and safety of continuing bevacizumab treatment after glioblastoma progression in newly diagnosed Japanese patients, consisting of 90 individuals receiving combined therapies with radiotherapy and temozolomide.
  • Key findings showed a median overall survival of 25.0 months and a median progression-free survival of 14.9 months, although the 2-year survival rate of the bevacizumab beyond progression (BBP) group fell short at 27.0%.
  • RNA sequencing revealed that a specific gene cluster (Cluster 2), associated with immune cell activation, could predict better survival outcomes, highlighting younger age and methylated tumors as additional positive indicators.
View Article and Find Full Text PDF

Pediatric neoplastic diseases account for about 10% of cases of fever of unknown origin (FUO), and most neoplastic disease cases are leukemia, lymphoma, and neuroblastoma. Brain tumors are rarely reported as the cause of FUO, although craniopharyngioma, metastatic brain tumor, and Castleman's disease have been reported. We report a case of intracranial mesenchymal tumor (IMT) with a FET:CREB fusion gene, which had inflammatory phenotype without neurological signs.

View Article and Find Full Text PDF

Background: Approximately 70% of lower-grade gliomas harbor isocitrate dehydrogenase 1 (IDH1) mutations, resulting in the accumulation of oncometabolite D-2-hydroxyglutarate (D-2-HG); this leads to epigenetic dysregulation, oncogenesis, and subsequent clonal expansion. DS-1001 is an oral brain-penetrant mutant IDH1 selective inhibitor. This first-in-human study investigated the safety, pharmacokinetics, pharmacodynamics, and efficacy of DS-1001.

View Article and Find Full Text PDF
Article Synopsis
  • * Treatment mainly involves chemotherapy and radiotherapy, with surgery being limited to certain cases; however, standardizing treatment is difficult due to the rarity of these tumors across institutions.
  • * In response to a higher incidence of GCTs in East Asia, the Japan Society for Neuro-Oncology developed comprehensive guidelines to aid healthcare professionals in clinical management, addressing diagnostics, treatment strategies, and long-term care for patients.
View Article and Find Full Text PDF

Background: Germinoma preferentially occurs in pediatric and young adult age groups. Although they are responsive to treatment with chemotherapy and radiation, the treatment may cause long-term sequelae in their later lives. Here, we searched for clinical and histopathological features to predict the prognosis of germinoma and affect treatment response.

View Article and Find Full Text PDF

Marginal zone B-cell lymphomas (MZBCLs) are non-Hodgkin lymphomas arising from postgerminal center marginal zone B cells. MZBCLs are subclassified into extranodal, nodal, and splenic MZBCLs. Primary nondural central nervous system (CNS) MZBCLs of the mucosa-associated lymphoid tissue (MALT) type are among the extranodal examples.

View Article and Find Full Text PDF

Isocitrate dehydrogenase-mutant low-grade gliomas (IDHmut-LGG) grow slowly but frequently undergo malignant transformation, which eventually leads to premature death. Chemotherapy and radiotherapy treatments prolong survival, but can also induce genetic (or epigenetic) alterations involved in transformation. Here, we developed a mathematical model of tumor progression based on serial tumor volume data and treatment history of 276 IDHmut-LGGs classified by chromosome 1p/19q codeletion (IDH/1p19q and IDH/1p19q) and performed genome-wide mutational analyses, including targeted sequencing and longitudinal whole-exome sequencing data.

View Article and Find Full Text PDF

Objective: The Japanese national immunization program recommends that children receive 4 doses of acellular pertussis vaccine between 3 months and 2 years of age. Nevertheless, the number of pertussis cases is increasing in elementary school children aged 6-12 years. Therefore, a test-negative case-control study was conducted to assess the effectiveness of the pertussis vaccine program.

View Article and Find Full Text PDF

A subset of central nervous system neuroblastomas (CNS NB), rare primary embryonal CNS tumors, has been encompassed in CNS NB with FOXR2 activation (CNS NB-FOXR2) and usually shows the primitive neuronal architecture and occasional neurocytic differentiation. Here, we report a rare case of 3-year-old female with uncommon morphology of CNS embryonal tumor with FOXR2 activation presenting bidirectional differentiation to neurocytic small primitive cells and astrocytic spindle cells both of which are positive for synaptophysin and GFAP. Ultrastructural study also showed that there were presynaptic structure and intermediate filament in the tumor cells, suggesting glioneuronal differentiation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate genetic changes and determine good responders to treatment in newly diagnosed glioblastoma (GBM) patients enrolled in the JCOG0911 trial, comparing the effects of interferonβ (IFNβ) combined with temozolomide (TMZ) versus TMZ alone.
  • Researchers analyzed 122 tumor samples using various sequencing methods to assess somatic mutations, promoter methylation, and tumor mutation burden, while also considering clinical factors like age and tumor location.
  • Key findings revealed important genetic markers, including IDH1 mutations in 14% of tumors and MGMT promoter methylation in 41%, with total tumor resection and MGMT methylation identified as favorable prognostic factors, while tumors
View Article and Find Full Text PDF

The purpose of this study is to measure the temporary intervals between R peak with ECG and pulse peak with photoplethysmography (PPG) and then to compare their precisions of two types of heart rate variability (HRV) analyses, power spectral analysis and Tone-Entropy analysis. A lot of papers used to measure cardiac autonomic nervous system (CANS) activity with HRV from PPI without awareness of the issue on another variability except CANS activity. Fifteen young male subjects were participated in this study.

View Article and Find Full Text PDF

Background: We integrated clinical, histopathological, and molecular data of central nervous system germ cell tumors to provide insights into their management.

Methods: Data from the Intracranial Germ Cell Tumor Genome Analysis (iGCT) Consortium were reviewed. A total of 190 cases were classified as primary germ cell tumors (GCTs) based on central pathological reviews.

View Article and Find Full Text PDF

Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions.

View Article and Find Full Text PDF

Glioblastomas are highly aggressive brain tumors with a particularly poor prognosis. Glucose transporter-1 (GLUT1/SLC2A1), a uniporter that is expressed by various carcinomas and may be involved in malignant neoplasm glycometabolism, may also be related to prognosis in glioblastomas. GLUT1 is essential to central nervous system glycometabolism.

View Article and Find Full Text PDF

We used an enzyme-linked immunosorbent assay to measure pretreatment B cell-activating factor belonging to the tumour necrosis factor family (BAFF) and transmembrane activator and CAML-interactor (TACI) levels in CSF and serum collected from patients with primary central nervous system lymphoma (PCNSL) and control groups. The decision tree analysis of CSF TACI and BAFF levels for patients with a PCNSL diagnosis showed 100% sensitivity and 100% specificity when we attempted to differentiate PCNSL from glioblastoma and CNS inflammatory diseases. The combination of CSF TACI and BAFF levels may thus be a novel and useful diagnostic biomarker of PCNSL.

View Article and Find Full Text PDF